Related Experiment Video
Updated: Feb 17, 2026

16:19
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
13.3K
Liver Transplantation in Cases with Acute Liver Failure
Mustafa Yalçin1, Göksel Bengİ1, Mesut Akarsu1
1Department of Gastroenterology, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey.
Euroasian Journal of Hepato-Gastroenterology
|December 5, 2017
Summary
Liver transplantation is a safe and effective treatment for acute liver failure (ALF). This study found toxicity to be the primary cause of ALF in patients undergoing this life-saving procedure.
Area of Science:
- Hepatology
- Transplant Surgery
- Critical Care Medicine
Background:
- Acute liver failure (ALF) is a severe, life-threatening condition marked by liver cell damage, jaundice, blood clotting issues, and brain dysfunction.
- Liver transplantation is a critical intervention for patients with ALF.
Purpose of the Study:
- To evaluate the outcomes of liver transplantation in patients with ALF at Dokuz Eylul University.
- To identify the primary causes of ALF leading to liver transplantation.
Main Methods:
- Retrospective evaluation of patients who underwent liver transplantation for ALF.
- Data analysis of patient demographics, causes of ALF, and transplantation outcomes.
Main Results:
- All liver transplantations performed were successful.
- Toxicity was identified as the predominant cause of ALF in 84% of the studied patients.
- The study highlights the successful application of liver transplantation in managing ALF.
Conclusions:
- Liver transplantation is a highly safe and effective treatment modality for acute liver failure.
- While results are from a single center, they align with broader evidence supporting liver transplantation for ALF.
- Further multi-regional studies may enhance generalizability across Turkey.
Related Concept Videos
Kidney Transplant I: Introduction
533
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
533
Kidney Transplant II: Surgical Procedure
477
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
477
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
258
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
258

